Literature DB >> 16791585

Use of an online surveillance system for screening drug interactions in prescriptions in community pharmacies.

Tiina Heikkilä1, Tuula Lekander, Hannu Raunio.   

Abstract

OBJECTIVE: Computerised surveillance systems have become available for screening potential adverse drug interactions during drug prescribing and dispensing. The purpose of this study was to analyse the frequency and profile of alerts given by one such system in two community pharmacies in Finland.
METHODS: In a prospective study, all interaction alerts given by the surveillance system were collated during September-November 2004 in two community pharmacies in Southern Finland. The alerts were categorised into four classes (A-D) according to their clinical significance.
RESULTS: During the 3-month study period, a total of 39,539 prescriptions were dispensed. The system flagged 3,861 prescriptions as having potential interactions (9.8% of all prescriptions). Since one prescription could be the source of several interaction alerts, a total of 5,647 alerts were given. The clinically most significant interactions (class D) represented 0.4% of prescriptions (3.0% of all interactions). Class C alerts were most prevalent (9.4% of all prescriptions, 65.9% of all interactions). The most commonly encountered interaction in class D was between warfarin and non-steroidal anti-inflammatory drugs.
CONCLUSIONS: Although the incidence of potentially most hazardous interactions in prescriptions is rather low in this study (0.4%), the overall incidence is relatively high (9.8%). Implementation of the interaction surveillance system in the participating pharmacies makes it possible to study in the future in quantitative terms whether the quality of drug dispensing is improved.

Entities:  

Mesh:

Year:  2006        PMID: 16791585     DOI: 10.1007/s00228-006-0149-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study.

Authors:  J Merlo; H Liedholm; U Lindblad; A Björck-Linné; J Fält; G Lindberg; A Melander
Journal:  BMJ       Date:  2001-08-25

2.  Exposure to potential drug interactions in primary health care.

Authors:  Lars Bjerrum; Morten Andersen; Gert Petersen; Jakob Kragstrup
Journal:  Scand J Prim Health Care       Date:  2003-09       Impact factor: 2.581

3.  Identification of inappropriate drug prescribing by computerized, retrospective DUR screening in Korea.

Authors:  Jong Hun Yeom; Jong Hum Yeom; Ji Sun Park; Ock-Hee Oh; Hyun Taek Shin; Jung Mi Oh
Journal:  Ann Pharmacother       Date:  2005-10-11       Impact factor: 3.154

4.  The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.

Authors:  Robyn Tamblyn; Allen Huang; Robert Perreault; André Jacques; Denis Roy; James Hanley; Peter McLeod; Réjean Laprise
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

5.  Preventing drug interactions by online prescription screening in community pharmacies and medical practices.

Authors:  H Halkin; I Katzir; I Kurman; J Jan; B B Malkin
Journal:  Clin Pharmacol Ther       Date:  2001-04       Impact factor: 6.875

6.  Drug-drug interactions among recently hospitalised patients--frequent but mostly clinically insignificant.

Authors:  Bente Glintborg; Stig Ejdrup Andersen; Kim Dalhoff
Journal:  Eur J Clin Pharmacol       Date:  2005-10-19       Impact factor: 2.953

7.  Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.

Authors:  Marisa Battistella; Muhammad M Mamdami; David N Juurlink; Linda Rabeneck; Andreas Laupacis
Journal:  Arch Intern Med       Date:  2005-01-24

8.  Nature, frequency and determinants of prescription modifications in Dutch community pharmacies.

Authors:  H Buurma; P A de Smet; O P van den Hoff; A C Egberts
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

Review 9.  Some aspects of genetic polymorphism in the biotransformation of antidepressants.

Authors:  Kim Brøsen
Journal:  Therapie       Date:  2004 Jan-Feb       Impact factor: 2.070

10.  Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.

Authors:  Sebastian Schneeweiss; Joerg Hasford; Martin Göttler; Annemarie Hoffmann; Ann-Kathrin Riethling; Jerry Avorn
Journal:  Eur J Clin Pharmacol       Date:  2002-06-12       Impact factor: 2.953

View more
  8 in total

1.  SFINX-a drug-drug interaction database designed for clinical decision support systems.

Authors:  Ylva Böttiger; Kari Laine; Marine L Andersson; Tuomas Korhonen; Björn Molin; Marie-Louise Ovesjö; Tuire Tirkkonen; Anders Rane; Lars L Gustafsson; Birgit Eiermann
Journal:  Eur J Clin Pharmacol       Date:  2009-02-11       Impact factor: 2.953

Review 2.  Predicting the clinical relevance of drug interactions from pre-approval studies.

Authors:  Silvio Caccia; Silvio Garattini; Luca Pasina; Alessandro Nobili
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece.

Authors:  Anna Chatsisvili; Ioakeim Sapounidis; Georgia Pavlidou; Eudoxia Zoumpouridou; Vasileios-Alexandros Karakousis; Marios Spanakis; Lefteris Teperikidis; Ioannis Niopas
Journal:  Pharm World Sci       Date:  2010-01-14

4.  Potential drug related problems detected by electronic expert support system in patients with multi-dose drug dispensing.

Authors:  Hammar Tora; Hovstadius Bo; Lidström Bodil; Petersson Göran; Eiermann Birgit
Journal:  Int J Clin Pharm       Date:  2014-06-29

Review 5.  Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature.

Authors:  Ehsan Nabovati; Hasan Vakili-Arki; Zhila Taherzadeh; Mohammad Reza Hasibian; Ameen Abu-Hanna; Saeid Eslami
Journal:  Daru       Date:  2014-06-25       Impact factor: 3.117

6.  Assessing the safety features of electronic patient medication record systems used in community pharmacies in England.

Authors:  Oluwagbemileke Ojeleye; Anthony J Avery; Matthew J Boyd
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

7.  Management of drug interactions with beta-blockers: continuing education has a short-term impact.

Authors:  Annelies Driesen; Steven Simoens; Gert Laekeman
Journal:  Pharm Pract (Granada)       Date:  2006

8.  Coordinating resources for prospective medication risk management of older home care clients in primary care: procedure development and RCT study design for demonstrating its effectiveness.

Authors:  Terhi Toivo; Maarit Dimitrow; Juha Puustinen; Eeva Savela; Katariina Pelkonen; Valtteri Kiuru; Tuula Suominen; Sirkka Kinnunen; Mira Uunimäki; Sirkka-Liisa Kivelä; Saija Leikola; Marja Airaksinen
Journal:  BMC Geriatr       Date:  2018-03-16       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.